CIZ.L

Cizzle Biotechnology Holdings Plc [CIZ.L] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

CIZ.L Stock Summary

In the News

CIZ.L Financial details

Company Rating
-
Market Cap
6.94M
Income
-953.48K
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
28 Jun 2024
P/E
-7.63
Forward P/E
-
PEG
0.93
P/S
-
P/B
2.64
P/C
-
P/FCF
-9.97
Quick Ratio
3.3
Current Ratio
4.86
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-87.3%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-17.48%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
100%
-
-
-
-
SMA20
-3.77%
SMA50
-19.05%
SMA100
-15.93%
Inst Own
-
Inst Trans
-
ROA
-33%
ROE
-51%
ROC
-0.36%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.675-3.8
52W High
-48.33%
52W Low
+55%
RSI
48.7
Rel Volume
0.33
Avg Volume
1.92M
Volume
624.45K
Perf Week
3.33%
Perf Month
-3.13%
Perf Quarter
-18.42%
Perf Half Y
-26.19%
-
-
-
-
Beta
0.353
-
-
Volatility
0.04%, 0.06%
Prev Close
-3.13%
Price
1.55
Change
-4.32%

Something similar

Top by Market Cap
V
NVD.DE
CMC.DE
JPM
VTSAX
Same Sector
300677.SZ
600196.SS
ODYY
IDIA.SW
LH
Same Price Range
ORTI-A.ST
002157.SZ
CMET.L
QAMC.QA
ALBDM.PA
Similar Market Cap
FAO.TO
PRM.MI
BFRI
SPO.L
EMTY

Company Profile

Healthcare Biotechnology

Cizzle Biotechnology Holdings Plc engages in development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.